3,3-DIBUTYL-7-(DIMETHYLAMINO)-1,1-DIOXIDO-4-HYDROXY-5-(4-HYDROXYPHENYL)-2,3,4,5-TETRAHYDROBENZOTHIEPINE, (4R,5R)-REL-
UNII FFN7E7444L
Substance Identification & Data
This profile provides standardized clinical and technical data for 3,3-dibutyl-7-(dimethylamino)-1,1-dioxido-4-hydroxy-5-(4-hydroxyphenyl)-2,3,4,5-tetrahydrobenzothiepine, (4r,5r)-rel-, uniquely identified by the FDA Unique Ingredient Identifier (UNII) FFN7E7444L.
Technical mappings include the Chemical Abstracts Service (CAS) Registry Number 197373-43-6 and the RxNorm Concept ID (RxCUI) N/A. Explore the sections below for detailed nomenclature and a complete directory of NDC-listed products containing this ingredient.
Detailed Substance Profile
C26H37NO4S ZISCLBWDEGJRBM-JWQCQUIFSA-N;ZISCLBWDEGJRBM-DQEYMECFSA-N Synonyms and Nomenclature
This section provides a complete list of nomenclature and identifier mappings for 3,3-dibutyl-7-(dimethylamino)-1,1-dioxido-4-hydroxy-5-(4-hydroxyphenyl)-2,3,4,5-tetrahydrobenzothiepine, (4r,5r)-rel-. Identifiers are organized into official regulatory terms, commercial trade names, and technical systematic synonyms used to ensure accurate identification across clinical pharmaceutical databases, regulatory filings, and electronic health records.